Regulation of the intestinal barrier function by host defense peptides

Frontiers in Veterinary Science

Volumn 2, Issue NOV, 2015, Pages

  Robinson, Kelsy ^a   Deng, Zhuo ^a   Hou, Yongqing ^b   Zhang, Guolong ^a,b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b WUHAN POLYTECHNIC UNIVERSITY   (China)

Author keywords

Barrier function; Gut health; Host defense peptides; Innate immunity; Tight junction

Indexed keywords

EID: 84976440571     PISSN: None     EISSN: 22971769     Source Type: Journal    
DOI: 10.3389/fvets.2015.00057     Document Type: Review

References (152)

1. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol (2009) 9:799-809. doi:10.1038/nri2653
2. Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol (2013) 10:352-61. doi:10.1038/nrgastro.2013.35
3. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 124:3-20; quiz 1-2. doi:10.1016/j.jaci.2009.05.038
4. Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol (2011) 32:256-64. doi:10.1016/j.it.2011.04.003
5. Liu D, Guo Y, Wang Z, Yuan J. Exogenous lysozyme influences Clostridium perfringens colonization and intestinal barrier function in broiler chickens. Avian Pathol (2010) 39:17-24. doi:10.1080/03079450903447404
6. Mani V, Weber TE, Baumgard LH, Gabler NK. Growth and development symposium: endotoxin, inflammation, and intestinal function in livestock. J Anim Sci (2012) 90:1452-65. doi:10.2527/jas.2011-4627
7. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature (2002) 415:389-95. doi:10.1038/415389a
8. Brogden KA, Ackermann M, McCray PB Jr, Tack BF. Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents (2003) 22:465-78. doi:10.1016/S0924-8579(03)00180-8
9. Hancock RE, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol (2012) 10:243-54. doi:10.1038/nrmicro2745
10. Hilchie AL, Wuerth K, Hancock RE. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol (2013) 9:761-8. doi:10.1038/nchembio.1393
11. Mansour SC, Pena OM, Hancock RE. Host defense peptides: front-line immunomodulators. Trends Immunol (2014) 35:443-50. doi:10.1016/j.it.2014.07.004
12. Kolls JK, McCray PB Jr, Chan YR. Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol (2008) 8:829-35. doi:10.1038/nri2433
13. Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 12:503-16. doi:10.1038/nri3228
14. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 6:551-7. doi:10.1038/ni1206
15. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol (2004) 75:39-48. doi:10.1189/jlb.0403147
16. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of s100 proteins. Curr Mol Med (2013) 13:24-57. doi:10.2174/1566524011307010024
17. Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer (2015) 15:96-109. doi:10.1038/nrc3893
18. Rosenberg HF. Rnase a ribonucleases and host defense: an evolving story. J Leukoc Biol (2008) 83:1079-87. doi:10.1189/jlb.1107725
19. Simanski M, Koten B, Schroder JM, Glaser R, Harder J. Antimicrobial RNAses in cutaneous defense. J Innate Immun (2012) 4:241-7. doi:10.1159/000335029
20. Santaolalla R, Abreu MT. Innate immunity in the small intestine. Curr Opin Gastroenterol (2012) 28:124-9. doi:10.1097/MOG.0b013e3283506559
21. Royet J, Gupta D, Dziarski R. Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nat Rev Immunol (2011) 11:837-51. doi:10.1038/nri3089
22. Patil A, Hughes AL, Zhang G. Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. Physiol Genomics (2004) 20:1-11. doi:10.1152/physiolgenomics.00150.2004
23. Patil AA, Cai Y, Sang Y, Blecha F, Zhang G. Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. Physiol Genomics (2005) 23:5-17. doi:10.1152/physiolgenomics.00104.2005
24. Meade KG, Cormican P, Narciandi F, Lloyd A, O'Farrelly C. Bovine beta-defensin gene family: opportunities to improve animal health? Physiol Genomics (2014) 46:17-28. doi:10.1152/physiolgenomics.00085.2013
25. Choi MK, Le MT, Nguyen DT, Choi H, Kim W, Kim JH, et al. Genome-level identification, gene expression, and comparative analysis of porcine ss-defensin genes. BMC Genet (2012) 13:98. doi:10.1186/1471-2156-13-98
26. Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, et al. A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins. BMC Genomics (2004) 5:56. doi:10.1186/1471-2164-5-56
27. Lynn DJ, Higgs R, Lloyd AT, O'farrelly C, Herve-Grepinet V, Nys Y, et al. Avian beta-defensin nomenclature: a community proposed update. Immunol Lett (2007) 110:86-9. doi:10.1016/j.imlet.2007.03.007
28. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R. The human gene fall39 and processing of the cathelin precursor to the antibacterial peptide ll-37 in granulocytes. Eur J Biochem (1996) 238:325-32. doi:10.1111/j.1432-1033.1996.0325z.x
29. Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, et al. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem (2006) 281:2858-67. doi:10.1074/jbc.M507180200
30. Goitsuka R, Chen CL, Benyon L, Asano Y, Kitamura D, Cooper MD. Chicken cathelicidin-b1, an antimicrobial guardian at the mucosal m cell gateway. Proc Natl Acad Sci U S A (2007) 104:15063-8. doi:10.1073/pnas.0707037104
31. Whelehan CJ, Barry-Reidy A, Meade KG, Eckersall PD, Chapwanya A, Narciandi F, et al. Characterisation and expression profile of the bovine cathelicidin gene repertoire in mammary tissue. BMC Genomics (2014) 15:128. doi:10.1186/1471-2164-15-128
32. Sang Y, Blecha F. Porcine host defense peptides: expanding repertoire and functions. Dev Comp Immunol (2009) 33:334-43. doi:10.1016/j.dci.2008.05.006
33. Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, et al. Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken. Immunogenetics (2004) 56:170-7. doi:10.1007/s00251-004-0675-0
34. Van Dijk A, Veldhuizen EJ, Van Asten AJ, Haagsman HP. Cmap27, a novel chicken cathelicidin-like antimicrobial protein. Vet Immunol Immunopathol (2005) 106:321-7. doi:10.1016/j.vetimm.2005.03.003
35. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (m) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol (2013) 6:666-77. doi:10.1038/mi.2013.30
36. Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 7:545-94. doi:10.3390/ph7050545
37. Xiao Y, Dai H, Bommineni YR, Soulages JL, Gong YX, Prakash O, et al. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J (2006) 273:2581-93. doi:10.1111/j.1742-4658.2006.05261.x
38. Bommineni YR, Dai H, Gong YX, Soulages JL, Fernando SC, Desilva U, et al. Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities. FEBS J (2007) 274:418-28. doi:10.1111/j.1742-4658.2006.05589.x
39. Xiao Y, Herrera AI, Bommineni YR, Soulages JL, Prakash O, Zhang G. The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization. J Innate Immun (2009) 1:268-80. doi:10.1159/000174822
40. Van Dijk A, Veldhuizen EJ, Haagsman HP. Avian defensins. Vet Immunol Immunopathol (2008) 124:1-18. doi:10.1016/j.vetimm.2007.12.006
41. Cuperus T, Coorens M, Van Dijk A, Haagsman HP. Avian host defense peptides. Dev Comp Immunol (2013) 41:352-69. doi:10.1016/j.dci.2013.04.019
42. Zhang G, Sunkara LT. Avian antimicrobial host defense peptides: from biology to therapeutic applications. Pharmaceuticals (Basel) (2014) 7:220-47. doi:10.3390/ph7030220
43. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol (2005) 3:238-50. doi:10.1038/nrmicro1098
44. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol (2006) 4:529-36. doi:10.1038/nrmicro1441
45. Nuding S, Zabel LT, Enders C, Porter E, Fellermann K, Wehkamp J, et al. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of hbd-3. Microbes Infect (2009) 11:384-93. doi:10.1016/j.micinf.2009.01.001
46. Bommineni YR, Pham GH, Sunkara LT, Achanta M, Zhang G. Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide. Mol Immunol (2014) 59:55-63. doi:10.1016/j.molimm.2014.01.004
47. Bommineni YR, Achanta M, Alexander J, Sunkara LT, Ritchey JW, Zhang G. A fowlicidin-1 analog protects mice from lethal infections induced by methicillin-resistant Staphylococcus aureus. Peptides (2010) 31:1225-30. doi:10.1016/j.peptides.2010.03.037
48. Mackenzie-Dyck S, Attah-Poku S, Juillard V, Babiuk LA, Van Drunen Littel-Van Den Hurk S. The synthetic peptides bovine enteric beta-defensin (ebd), bovine neutrophil beta-defensin (bnbd) 9 and bnbd 3 are chemotactic for immature bovine dendritic cells. Vet Immunol Immunopathol (2011) 143:87-107. doi:10.1016/j.vetimm.2011.06.028
49. Ikeda Y, Young LH, Scalia R, Ross CR, Lefer AM. Pr-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion. Cardiovasc Res (2001) 49:69-77. doi:10.1016/S0008-6363(00)00226-1
50. Shi J, Ross CR, Leto TL, Blecha F. Pr-39, a proline-rich antibacterial peptide that inhibits phagocyte nadph oxidase activity by binding to src homology 3 domains of p47 phox. Proc Natl Acad Sci U S A (1996) 93:6014-8. doi:10.1073/pnas.93.12.6014
51. Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A (1994) 91:11035-9. doi:10.1073/pnas.91.23.11035
52. Li J, Post M, Volk R, Gao Y, Li M, Metais C, et al. Pr39, a peptide regulator of angiogenesis. Nat Med (2000) 6:49-55. doi:10.1038/71527
53. Baumann A, Demoulins T, Python S, Summerfield A. Porcine cathelicidins efficiently complex and deliver nucleic acids to plasmacytoid dendritic cells and can thereby mediate bacteria-induced ifn-alpha responses. J Immunol (2014) 193:364-71. doi:10.4049/jimmunol.1303219
54. Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochim Biophys Acta (2015) 1850:236-52. doi:10.1016/j.bbagen.2014.05.003
55. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol (2008) 1:183-97. doi:10.1038/mi.2008.5
56. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev (2006) 86:245-78. doi:10.1152/physrev.00010.2005
57. Etzold S, Juge N. Structural insights into bacterial recognition of intestinal mucins. Curr Opin Struct Biol (2014) 28:23-31. doi:10.1016/j.sbi.2014.07.002
58. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer (2004) 4:45-60. doi:10.1038/nrc1251
59. Hoorens PR, Rinaldi M, Li RW, Goddeeris B, Claerebout E, Vercruysse J, et al. Genome wide analysis of the bovine mucin genes and their gastrointestinal transcription profile. BMC Genomics (2011) 12:140. doi:10.1186/1471-2164-12-140
60. Kim CH, Oh Y, Ha Y, Ahn Q, Kim SH, Cho KD, et al. Expression of mucins in the mucosal surface of small intestines in 1 week-old pigs. J Vet Med Sci (2010) 72:245-7. doi:10.1292/jvms.09-0308
61. Kim CH, Lee K, Han K, Oh Y, Kim D, Seo HW, et al. Expression of mucins on the mucosal surface of lungs of 4-week-old pigs. Vet Res Commun (2011) 35:255-60. doi:10.1007/s11259-011-9465-y
62. Lang T, Hansson GC, Samuelsson T. An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins. BMC Genomics (2006) 7:197. doi:10.1186/1471-2164-7-197
63. Van Der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, et al. Muc2-deficient mice spontaneously develop colitis, indicating that Muc2 is critical for colonic protection. Gastroenterology (2006) 131:117-29. doi:10.1053/j.gastro.2006.04.020
64. Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog (2010) 6:e1000902. doi:10.1371/journal.ppat.1000902
65. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, et al. Muc1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest (2007) 117:2313-24. doi:10.1172/JCI26705
66. McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, Swierczak A, et al. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology (2007) 133:1210-8. doi:10.1053/j.gastro.2007.07.003
67. Zarepour M, Bhullar K, Montero M, Ma C, Huang T, Velcich A, et al. The mucin muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar typhimurium colitis. Infect Immun (2013) 81:3672-83. doi:10.1128/IAI.00854-13
68. An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med (2007) 204:1417-29. doi:10.1084/jem.20061929
69. Buisine MP, Desreumaux P, Debailleul V, Gambiez L, Geboes K, Ectors N, et al. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis (1999) 5:24-32. doi:10.1002/ibd.3780050105
70. Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci (2001) 6:D1321-57. doi:10.2741/Corfield
71. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol (2014) 14:141-53. doi:10.1038/nri3608
72. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci (2013) 70:631-59. doi:10.1007/s00018-012-1070-x
73. Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev (2013) 93:525-69. doi:10.1152/physrev.00019.2012
74. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol (1993) 123:1777-88. doi:10.1083/jcb.123.6.1777
75. Cummins PM. Occludin: one protein, many forms. Mol Cell Biol (2012) 32:242-50. doi:10.1128/MCB.06029-11
76. Luissint AC, Nusrat A, Parkos CA. JAM-related proteins in mucosal homeostasis and inflammation. Semin Immunopathol (2014) 36:211-26. doi:10.1007/s00281-014-0421-0
77. Kojima T, Ninomiya T, Konno T, Kohno T, Taniguchi M, Sawada N. Expression of tricellulin in epithelial cells and non-epithelial cells. Histol Histopathol (2013) 28:1383-92. doi:10.14670/HH-28.1383
78. Herve JC, Derangeon M, Sarrouilhe D, Bourmeyster N. Influence of the scaffolding protein zonula occludens (ZOs) on membrane channels. Biochim Biophys Acta (2014) 1838:595-604. doi:10.1016/j.bbamem.2013.07.006
79. Citi S, Pulimeno P, Paschoud S. Cingulin, paracingulin, and plekha7: signaling and cytoskeletal adaptors at the apical junctional complex. Ann N Y Acad Sci (2012) 1257:125-32. doi:10.1111/j.1749-6632.2012.06506.x
80. Suzuki H, Nishizawa T, Tani K, Yamazaki Y, Tamura A, Ishitani R, et al. Crystal structure of a claudin provides insight into the architecture of tight junctions. Science (2014) 344:304-7. doi:10.1126/science.1248571
81. Suzuki H, Tani K, Tamura A, Tsukita S, Fujiyoshi Y. Model for the architecture of claudin-based paracellular ion channels through tight junctions. J Mol Biol (2015) 427:291-7. doi:10.1016/j.jmb.2014.10.020
82. Mariano C, Sasaki H, Brites D, Brito MA. A look at tricellulin and its role in tight junction formation and maintenance. Eur J Cell Biol (2011) 90:787-96. doi:10.1016/j.ejcb.2011.06.005
83. Ebnet K, Suzuki A, Ohno S, Vestweber D. Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci (2004) 117:19-29. doi:10.1242/jcs.00930
84. Al-Sadi R, Khatib K, Guo S, Ye D, Youssef M, Ma T. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol (2011) 300:G1054-64. doi:10.1152/ajpgi.00055.2011
85. Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci (2012) 1258:34-42. doi:10.1111/j.1749-6632.2012.06526.x
86. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol (2006) 290:G496-504. doi:10.1152/ajpgi.00318.2005
87. Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol (2008) 180:5653-61. doi:10.4049/jimmunol.180.8.5653
88. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol (1999) 147:195-204. doi:10.1083/jcb.147.1.195
89. Smith F, Clark JE, Overman BL, Tozel CC, Huang JH, Rivier JE, et al. Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am J Physiol Gastrointest Liver Physiol (2010) 298:G352-63. doi:10.1152/ajpgi.00081.2009
90. Hu CH, Xiao K, Luan ZS, Song J. Early weaning increases intestinal permeability, alters expression of cytokine and tight junction proteins, and activates mitogen-activated protein kinases in pigs. J Anim Sci (2013) 91:1094-101. doi:10.2527/jas.2012-5796
91. Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol (2014) 20:1165-79. doi:10.3748/wjg.v20.i5.1165
92. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced paneth cell alpha-defensins in ileal crohn's disease. Proc Natl Acad Sci U S A (2005) 102:18129-34. doi:10.1073/pnas.0505256102
93. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 107:8772-7. doi:10.1073/pnas.0905745107
94. Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol (2002) 14:745-52. doi:10.1097/00042737-200207000-00006
95. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2003) 9:215-23. doi:10.1097/00054725-200307000-00001
96. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. Beta-defensin-3 and-4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol (2004) 137:379-85. doi:10.1111/j.1365-2249.2004.02543.x
97. Schauber J, Rieger D, Weiler F, Wehkamp J, Eck M, Fellermann K, et al. Heterogeneous expression of human cathelicidin hCAP18/ll-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol (2006) 18:615-21. doi:10.1097/00042737-200606000-00007
98. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, et al. Nod2 (card15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 53:1658-64. doi:10.1136/gut.2003.032805
99. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 307:731-4. doi:10.1126/science.1104911
100. Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol (2008) 128:917-25. doi:10.1038/sj.jid.5701099
101. Otte JM, Werner I, Brand S, Chromik AM, Schmitz F, Kleine M, et al. Human beta defensin 2 promotes intestinal wound healing in vitro. J Cell Biochem (2008) 104:2286-97. doi:10.1002/jcb.21787
102. Cobo ER, Kissoon-Singh V, Moreau F, Chadee K. Colonic muc2 mucin regulates the expression and antimicrobial activity of beta-defensin 2. Mucosal Immunol (2015) 8(6):1360-72. doi:10.1038/mi.2015.27
103. Tai EK, Wong HP, Lam EK, Wu WK, Yu L, Koo MW, et al. Cathelicidin stimulates colonic mucus synthesis by up-regulating Muc1 and Muc2 expression through a mitogen-activated protein kinase pathway. J Cell Biochem (2008) 104:251-8. doi:10.1002/jcb.21615
104. Otte JM, Zdebik AE, Brand S, Chromik AM, Strauss S, Schmitz F, et al. Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept (2009) 156:104-17. doi:10.1016/j.regpep.2009.03.009
105. Tang ZR, Deng H, Zhang XL, Zen Y, Xiao DF, Sun WZ, et al. Effects of orally administering the antimicrobial peptide buforin II on small intestinal mucosal membrane integrity, the expression of tight junction proteins and protective factors in weaned piglets challenged by enterotoxigenic Escherichia coli. Anim Feed Sci Technol (2013) 186:177-85. doi:10.1016/j.anifeedsci.2013.10.012
106. Song D, Zong X, Zhang H, Wang T, Yi H, Luan C, et al. Antimicrobial peptide cathelicidin-BF prevents intestinal barrier dysfunction in a mouse model of endotoxemia. Int Immunopharmacol (2015) 25:141-7. doi:10.1016/j.intimp.2015.01.017
107. Han F, Zhang H, Xia X, Xiong H, Song D, Zong X, et al. Porcine beta-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. J Immunol (2015) 194:1882-93. doi:10.4049/jimmunol.1402300
108. Zhang Y, Zhu M, Yang Z, Pan X, Jiang Y, Sun C, et al. The human cathelicidin LL-37 induces muc5ac mucin production by airway epithelial cells via TACE-TGF-alpha-EGFR pathway. Exp Lung Res (2014) 40:333-42. doi:10.3109/01902148.2014.926434
109. Akiyama T, Niyonsaba F, Kiatsurayanon C, Nguyen TT, Ushio H, Fujimura T, et al. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function. J Innate Immun (2014) 6:739-53. doi:10.1159/000362789
110. Kiatsurayanon C, Niyonsaba F, Smithrithee R, Akiyama T, Ushio H, Hara M, et al. Host defense (antimicrobial) peptide, human beta-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes. J Invest Dermatol (2014) 134:2163-73. doi:10.1038/jid.2014.143
111. Hattori F, Kiatsurayanon C, Okumura K, Ogawa H, Ikeda S, Okamoto K, et al. The antimicrobial protein S100a7/psoriasin enhances the expression of keratinocyte differentiation markers and strengthens the skin's tight junction barrier. Br J Dermatol (2014) 171:742-53. doi:10.1111/bjd.13125
112. Choi KY, Chow LN, Mookherjee N. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J Innate Immun (2012) 4:361-70. doi:10.1159/000336630
113. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol (2010) 87:989-99. doi:10.1189/jlb.1209775
114. Iitaka D, Moodley S, Shimizu H, Bai XH, Liu M. PKCdelta-iPLA2-PGE2-PPARgamma signaling cascade mediates TNF-alpha induced claudin 1 expression in human lung carcinoma cells. Cell Signal (2015) 27:568-77. doi:10.1016/j.cellsig.2014.12.015
115. Iden S, Misselwitz S, Peddibhotla SS, Tuncay H, Rehder D, Gerke V, et al. aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation. J Cell Biol (2012) 196:623-39. doi:10.1083/jcb.201104143
116. Suzuki A, Ishiyama C, Hashiba K, Shimizu M, Ebnet K, Ohno S. aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. J Cell Sci (2002) 115:3565-73. doi:10.1242/jcs.00032
117. Beurel E, Michalek SM, Jope RS. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol (2010) 31:24-31. doi:10.1016/j.it.2009.09.007
118. Severson EA, Kwon M, Hilgarth RS, Parkos CA, Nusrat A. Glycogen synthase kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and e-cadherin expression. Biochem Biophys Res Commun (2010) 397:592-7. doi:10.1016/j.bbrc.2010.05.164
119. González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta (2008) 1778:729-56. doi:10.1016/j.bbamem.2007.08.018
120. Little D, Dean RA, Young KM, McKane SA, Martin LD, Jones SL, et al. PI3K signaling is required for prostaglandin-induced mucosal recovery in ischemia-injured porcine ileum. Am J Physiol Gastrointest Liver Physiol (2003) 284:G46-56. doi:10.1152/ajpgi.00121.2002
121. Woo PL, Ching D, Guan Y, Firestone GL. Requirement for ras and phosphatidylinositol 3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical resistance in mammary tumor cells. J Biol Chem (1999) 274:32818-28. doi:10.1074/jbc.274.46.32818
122. Su B, Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol (1996) 8:402-11. doi:10.1016/S0952-7915(96)80131-2
123. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature (2012) 489:220-30. doi:10.1038/nature11550
124. Saulnier DM, Kolida S, Gibson GR. Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des (2009) 15:1403-14. doi:10.2174/138161209788168128
125. Salzman NH. Paneth cell defensins and the regulation of the microbiome: detente at mucosal surfaces. Gut Microbes (2010) 1:401-6. doi:10.4161/gmic.1.6.14076
126. McDermott AJ, Huffnagle GB. The microbiome and regulation of mucosal immunity. Immunology (2014) 142:24-31. doi:10.1111/imm.12231
127. Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota. Trends Immunol (2014) 35:507-17. doi:10.1016/j.it.2014.07.010
128. Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med (2013) 5:1465-83. doi:10.1002/emmm.201201773
129. Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, Law I, et al. Cathelicidin signaling via the toll-like receptor protects against colitis in mice. Gastroenterology (2011) 141(1852-63):e1-3. doi:10.1053/j.gastro.2011.06.079
130. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 422:522-6. doi:10.1038/nature01520
131. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 286:113-7. doi:10.1126/science.286.5437.113
132. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2010) 11:76-83. doi:10.1038/ni.1825
133. Xiao H, Shao F, Wu M, Ren W, Xiong X, Tan B, et al. The application of antimicrobial peptides as growth and health promoters for swine. J Anim Sci Biotechnol (2015) 6:19. doi:10.1186/s40104-015-0018-z
134. Wang S, Thacker PA, Watford M, Qiao S. Functions of antimicrobial peptides in gut homeostasis. Curr Protein Pept Sci (2015) 16:582-91. doi:10.2174/1389203716666150630135847
135. Cutler SA, Lonergan SM, Cornick N, Johnson AK, Stahl CH. Dietary inclusion of colicin E1 is effective in preventing postweaning diarrhea caused by F18-positive Escherichia coli in pigs. Antimicrob Agents Chemother (2007) 51:3830-5. doi:10.1128/AAC.00360-07
136. Wu S, Zhang F, Huang Z, Liu H, Xie C, Zhang J, et al. Effects of the antimicrobial peptide cecropin ad on performance and intestinal health in weaned piglets challenged with Escherichia coli. Peptides (2012) 35:225-30. doi:10.1016/j.peptides.2012.03.030
137. Tang XS, Fatufe AA, Yin YL, Tang ZR, Wang SP, Liu ZQ, et al. Dietary supplementation with recombinant lactoferrampin-lactoferricin improves growth performance and affects serum parameters in piglets. J Anim Vet Adv (2012) 11:2548-55. doi:10.3923/javaa.2012.2548.2555
138. Xiong X, Yang HS, Li L, Wang YF, Huang RL, Li FN, et al. Effects of antimicrobial peptides in nursery diets on growth performance of pigs reared on five different farms. Livest Sci (2014) 167:206-10. doi:10.1016/j.livsci.2014.04.024
139. Yoon JH, Ingale SL, Kim JS, Kim KH, Lohakare J, Park YK, et al. Effects of dietary supplementation with antimicrobial peptide-P5 on growth performance, apparent total tract digestibility, faecal and intestinal microflora and intestinal morphology of weanling pigs. J Sci Food Agric (2013) 93:587-92. doi:10.1002/jsfa.5840
140. Yoon JH, Ingale SL, Kim JS, Kim KH, Lee SH, Park YK, et al. Effects of dietary supplementation of synthetic antimicrobial peptide-A3 and P5 on growth performance, apparent total tract digestibility of nutrients, fecal and intestinal microflora and intestinal morphology in weanling pigs. Livest Sci (2014) 159:53-60. doi:10.1016/j.livsci.2013.10.025
141. Xiao H, Wu MM, Tan BE, Yin YL, Li TJ, Xiao DF, et al. Effects of composite antimicrobial peptides in weanling piglets challenged with deoxynivalenol: I. Growth performance, immune function, and antioxidation capacity. J Anim Sci (2013) 91:4772-80. doi:10.2527/jas.2013-6426
142. Xiao H, Tan BE, Wu MM, Yin YL, Li TJ, Yuan DX, et al. Effects of composite antimicrobial peptides in weanling piglets challenged with deoxynivalenol: II. Intestinal morphology and function. J Anim Sci (2013) 91:4750-6. doi:10.2527/jas.2013-6427
143. Choi SC, Ingale SL, Kim JS, Park YK, Kwon IK, Chae BJ. An antimicrobial peptide-A3: effects on growth performance, nutrient retention, intestinal and faecal microflora and intestinal morphology of broilers. Br Poult Sci (2013) 54:738-46. doi:10.1080/00071668.2013.838746
144. Wen LF, He JG. Dose-response effects of an antimicrobial peptide, a cecropin hybrid, on growth performance, nutrient utilisation, bacterial counts in the digesta and intestinal morphology in broilers. Br J Nutr (2012) 108:1756-63. doi:10.1017/S0007114511007240
145. Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, Scheppach W, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut (2003) 52:735-41. doi:10.1136/gut.52.5.735
146. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A (2006) 103:9178-83. doi:10.1073/pnas.0602888103
147. Ochoa-Zarzosa A, Villarreal-Fernandez E, Cano-Camacho H, Lopez-Meza JE. Sodium butyrate inhibits Staphylococcus aureus internalization in bovine mammary epithelial cells and induces the expression of antimicrobial peptide genes. Microb Pathog (2009) 47:1-7. doi:10.1016/j.micpath.2009.04.006
148. Sunkara LT, Achanta M, Schreiber NB, Bommineni YR, Dai G, Jiang W, et al. Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression. PLoS One (2011) 6:e27225. doi:10.1371/journal.pone.0027225
149. Sunkara LT, Jiang W, Zhang G. Modulation of antimicrobial host defense peptide gene expression by free fatty acids. PLoS One (2012) 7:e49558. doi:10.1371/journal.pone.0049558
150. Zeng X, Sunkara LT, Jiang W, Bible M, Carter S, Ma X, et al. Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogs. PLoS One (2013) 8:e72922. doi:10.1371/journal.pone.0072922
151. Sunkara LT, Zeng X, Curtis AR, Zhang G. Cyclic AMP synergizes with butyrate in promoting beta-defensin 9 expression in chickens. Mol Immunol (2014) 57:171-80. doi:10.1016/j.molimm.2013.09.003
152. Lyu W, Curtis AR, Sunkara LT, Zhang G. Transcriptional regulation of antimicrobial host defense peptides. Curr Protein Pept Sci (2015) 16:672-9. doi:10.2174/1389203716666150630133432